Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.45 is 14% below its 5-year average of 4.04, near the low end of its 5-year range (2.72–5.46).
As of the fiscal period ended Tuesday, June 30, 2026. 4.72% below its 12-month average of 3.62.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.45.
QUICK RATIO (ACID-TEST)
3.45
QUICK RATIO (ACID-TEST) AVG TTM
3.62
QUICK RATIO (ACID-TEST) AVG 3Y
3.43
QUICK RATIO (ACID-TEST) AVG 5Y
4.04
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.72%
CURRENT VS 3Y AVG
+0.62%
CURRENT VS 5Y AVG
-14.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+2.89%
vs the sector median at left
Harmony Biosciences Holdings, Inc.
Market Cap
$2.28B
Quick Ratio (Acid-Test)
3.45
TTM Avg
3.62
3Y Avg
3.43
5Y Avg
4.04
Market Cap
$2.30B
Quick Ratio (Acid-Test)
2.12
TTM Avg
2.91
3Y Avg
5.50
5Y Avg
6.00
Market Cap
$2.24B
Quick Ratio (Acid-Test)
10.23
TTM Avg
3.96
3Y Avg
3.96
5Y Avg
3.96
Market Cap
$2.34B
Quick Ratio (Acid-Test)
1.72
TTM Avg
1.46
3Y Avg
1.33
5Y Avg
1.71
Market Cap
$2.35B
Quick Ratio (Acid-Test)
6.34
TTM Avg
6.74
3Y Avg
5.35
5Y Avg
5.47
Market Cap
$2.36B
Quick Ratio (Acid-Test)
3.81
TTM Avg
3.32
3Y Avg
2.77
5Y Avg
2.91
Market Cap
$2.37B
Quick Ratio (Acid-Test)
24.14
TTM Avg
21.55
3Y Avg
17.24
5Y Avg
12.65
Market Cap
$2.17B
Quick Ratio (Acid-Test)
11.94
TTM Avg
11.36
3Y Avg
14.72
5Y Avg
18.03
Market Cap
$2.38B
Quick Ratio (Acid-Test)
1.50
TTM Avg
1.54
3Y Avg
1.54
5Y Avg
1.56
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | $2.28B | 3.45 | 3.62 | 3.43 | 4.04 |
| Liquidia Corporation (LQDA)vs › | $2.30B | 2.12 | 2.91 | 5.50 | 6.00 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | 10.23 | 3.96 | 3.96 | 3.96 |
| UFP Technologies, Inc. (UFPT)vs › | $2.34B | 1.72 | 1.46 | 1.33 | 1.71 |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | 6.34 | 6.74 | 5.35 | 5.47 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 3.81 | 3.32 | 2.77 | 2.91 |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | 24.14 | 21.55 | 17.24 | 12.65 |
| Pharvaris N.V. (PHVS)vs › | $2.17B | 11.94 | 11.36 | 14.72 | 18.03 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | 1.50 | 1.54 | 1.54 | 1.56 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | 2.98 | 6.17 | 6.76 | 6.11 |
Quick Ratio
3.45
Excludes inventory
Current Ratio
3.48
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.45 |
| 2026-03-31 | 3.56 |
| 2025-12-31 | 3.58 |
| 2025-09-30 | 3.72 |
| 2025-06-30 | 3.80 |
| 2025-03-31 | 3.63 |
| 2024-12-31 | 3.27 |
| 2024-09-30 | 3.20 |
| 2024-06-30 | 3.09 |
| 2024-03-31 | 3.07 |
| 2023-12-31 | 2.72 |
| 2023-09-30 | 4.07 |
| 2023-06-30 | 4.84 |
| 2023-03-31 | 4.85 |
| 2022-12-31 | 5.02 |
| 2022-09-30 | 3.52 |
| 2022-06-30 | 4.84 |
| 2022-03-31 | 4.88 |
| 2021-12-31 | 5.21 |
| 2021-09-30 | 4.95 |
| 2021-06-30 | 5.46 |
| 2021-03-31 | 5.18 |
| 2020-12-31 | 1.93 |
| 2020-09-30 | 7.80 |
| 2020-06-30 | 4.57 |
| 2020-03-31 | 5.39 |
| 2019-12-31 | 1.53 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
